Eurofins
在场
是其中之一......
Eurofins 是一家在股票代码 ERF (FR) 下上市的公司。
Eurofins 在 10 个国家有直接业务。Eurofins 拥有 20家子公司，其中包括 Biomnis Ireland、Boston Heart Diagnostics 和 EAG。
他们在：
高管
查看带有其 130 名主要高管的组织结构图
Eurofins 搜索最多的简介
- Gilles Martin, Chairman of the Board and Chief Executive Officer
- Valerie Hanote, Non-Executive Director
- Yves-Loic Martin, Director
创建提醒
跟踪 Eurofins 的高管变动
生物技术
Eurofins 拥有 2,327 家竞争者，其中包括 Lonza (瑞士)、Biogen (美国(美洲)) 和 Genus (联合王国)。
Popular M&A news in 生物技术
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
- Metsera 刚刚宣布为 500 筹款数百万美元。 (公布2024十一月20号).
- TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).
生物技术 行业的其他推荐联系人
消息
Eurofins 的最新新闻稿
- New Business Development Lead | Agriculture Technologies
- Plant Visual Injury | Published Article
- Eurofins SAFE HARBOR STATEMENT - Eurofins Scientific
- Eurofins raises EUR 535m following a successful equity issuance - Eurofins Scientific
- Eurofins announces the issuance of c. 900,000 new shares via an accelerated book building offering to institutional investors in order to support its rapid build-up of COVID-19 testing capacities - Eurofins Scientific
- Eurofins announces the success of its Tender Offers on its outstanding 2022 bonds and 2023 bonds - Eurofins Scientific
- Eurofins Technologies launches multiplex Real-Time PCR assay for SARS-CoV-2 (coronavirus) pathogen detection - Eurofins Scientific
- Eurofins successfully prices new EUR 600m senior unsecured Euro bonds in the context of the refinancing of its outstanding 2022 and 2023 bonds - Eurofins Scientific
- Eurofins announces its intention to issue new Bonds of benchmark size to repurchase some of its EUR 500M Bonds due 27 January 2022 and its EUR 500M Bonds due 30 January 2023 - Eurofins Scientific
- Eurofins scientists develop multiple new solutions to support the world’s fight against the COVID-19 pandemic – ramping up production to enable over 20 million patients tests per month by end May 2020 - Eurofins Scientific
- View more press releases Close
通过电子邮件
